Welcome to Medications.com

Oryx Pharmaceuticals Announces Launch of Naprelan - PharmaLive.com (press release)

NAPRELAN(TM) is approved in Canada for the management of signs and symptoms of rheumatoid arthritis and osteoarthritis and is available in strengths of 375 ...

http://www.pharmalive.com/News/in... | Posted: Tue Jul 17 06:33:41 -0400 2007




Frequently Reported Side Effects of Naprelan '375'

specifically, gout, food
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea